Adaptimmune Therapeutics(DE:473A)
€0.010.00 (0.00%)
DE:473A
Adaptimmune Therapeutics earnings date
€0.01
At close:0.00 (0.00%)
Adaptimmune Therapeutics (473A) Q2 2024 Earnings Report
0 Followers
DE:473A Q2 2024 EPS Results
- Actual EPS
- EUR 0.04
- Consensus EPS
- -EUR 0.04
- Beat/Miss
- Beat by +EUR 0.08
- One Year Ago EPS
- -EUR 0.02
DE:473A Q2 2024 Revenue Results
- Actual Revenue
- EUR 114.94M
- Expected Revenue
- EUR 36.23M
- Beat/Miss
- Beat by +EUR 78.70M
- YoY Revenue Growth
- +2393.48%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/12/2024
- Time
- Before Open
- Conference Call
- Monday, August 12, 2024
Q2 2024 Earnings Call Audio
DE:473A Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:473A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 12, 2026 | 2026 (Q2) | ―- | -0.1 | ― | |
| May 20, 2026 | 2026 (Q1) | -0.03- | -0.03 | ― | |
| Mar 10, 2026 | 2025 (Q4) | -0.05-0.03 | -0.04 | 40.00% (+0.02) | |
| Nov 05, 2025 | 2025 (Q3) | -0.11- | -0.01 | ― | |
| Aug 13, 2025 | 2025 (Q2) | -0.04-0.02 | 0.04 | -150.00% (-0.05) | |
| May 13, 2025 | 2025 (Q1) | -0.08-0.03 | -0.03 | 0.00% (+0.00) | |
| Mar 20, 2025 | 2024 (Q4) | -0.03-0.04 | -0.04 | -25.00% (-0.01) | |
| Nov 13, 2024 | 2024 (Q3) | -0.01-0.01 | -0.03 | 66.67% (+0.02) | |
| Aug 12, 2024 | 2024 (Q2) | -0.040.04 | -0.02 | 300.00% (+0.05) | |
| May 15, 2024 | 2024 (Q1) | -0.14-0.03 | 0 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
